Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Agile Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Agile Therapeutics

Agile Therapeutics

Public

Agile Therapeutics: A NJ-based women's health firm specializing in developing prescription contraceptives.

HQ
Princeton, NJ, US
Founded
1997
Overview
Compare
Fundraising
Employees
Website

Agile Therapeutics, founded in Princeton, New Jersey, is a women's health specialty pharmaceutical company dedicated to developing and commercializing prescription contraceptive products. The company's core mission is to provide women with more healthcare choices through innovative contraceptive solutions. Their flagship product, Twirla, utilizes their proprietary SkinFusion® technology to enhance drug administration and wearability, addressing the needs of women seeking reliable and convenient birth control options.

Notable figures associated with Agile Therapeutics include its experienced leadership team and a board of directors with extensive backgrounds in pharmaceuticals and healthcare. The company has secured investments from prominent healthcare-focused venture capital firms. Key achievements include the FDA approval of Twirla, marking a significant milestone in expanding contraceptive options for women. Agile Therapeutics continues to impact the market by prioritizing women's health and offering advanced contraceptive solutions.

Agile Therapeutics - Similar Companies

Agile Sciences logo

Agile Sciences

agilesci.com

SynAgile logo

SynAgile

Aquestive Therapeutics logo

Aquestive Therapeutics

aquestive.com

Applied Therapeutics logo

Applied Therapeutics

Aggamin logo

Aggamin

Agilvax logo

Agilvax

Zena Therapeutics logo

Zena Therapeutics

Evofem Biosciences logo

Evofem Biosciences

evofem.com

Cara Therapeutics logo

Cara Therapeutics

United Therapeutics logo

United Therapeutics

Azure Biotech logo

Azure Biotech

azurebiotech.com

Aegle Therapeutics logo

Aegle Therapeutics

Estrigenix Therapeutics logo

Estrigenix Therapeutics

estrigenix.com

YourChoice Therapeutics logo

YourChoice Therapeutics

yourchoicetx.com

Aspira Women's Health logo

Aspira Women's Health

aspirawh.com

Agile Therapeutics - Quick Facts

Who are Agile Therapeutics' competitors?

Companies similar to Agile Therapeutics include Agile Sciences, SynAgile, Aquestive Therapeutics and Applied Therapeutics.

When was Agile Therapeutics founded?

Agile Therapeutics was founded in 1997.

Where is Agile Therapeutics' headquarters located?

Agile Therapeutics' headquarters is located in Princeton, NJ, US.

When was Agile Therapeutics' last funding round?

Agile Therapeutics' most recent funding round was for $7.5M (USD) in May 2023.

How much has Agile Therapeutics raised to-date?

As of May 22, 2023, Agile Therapeutics has raised a total of $240.8M (USD).

How many employees does Agile Therapeutics have?

Agile Therapeutics has 22 employees as of Feb 6, 2024.

Agile Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Contraceptives
Tags
  • Healthtech
  • Pharmaceutical
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8733Noncommercial Research Organizations
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering